Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs

Lauren L Knight; Katherine Wagner; Yuridia Leyva; Veronica R Bruce; Kirsten A M White; Yvonne S Talamantes; Brittany Price; Kimberly Page; Martha L Carvour

doi:10.1177/1524839918799455

Back

Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs

Journal article

Peer reviewed

Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs

Lauren L Knight, Katherine Wagner, Yuridia Leyva, Veronica R Bruce, Kirsten A M White, Yvonne S Talamantes, Brittany Price, Kimberly Page and Martha L Carvour

Health promotion practice, Vol.19(6), pp.815-822

11/2018

DOI: 10.1177/1524839918799455

PMCID: PMC6436913

PMID: 30227752

Files and links (1)

url

https://www.ncbi.nlm.nih.gov/pmc/articles/6436913View

Open Access

Abstract

Young adults who inject drugs and live in rural communities are at high risk for hepatitis C virus (HCV) infection. Recent changes in HCV treatment must be communicated within these communities to improve access to care and reduce HCV transmission. Field workers in the ¡VÁLE! Hepatitis Treatment and Integrated Prevention Services study identified frequently asked questions (FAQs) posed by young-adult participants at high risk for HCV during screening and educational sessions. From 2016 to 2018, 183 young adults (44.3% women; 85.8% Latino/a) younger than 30 years who inject drugs and reside in Rio Arriba or Doña Ana counties in New Mexico were enrolled. The research team compiled deidentified questions during field enrollments. FAQs were reviewed and categorized into four major domains, including risk/prevention, screening, treatment, and reinfection. FAQs were addressed by a team of medical and public health professionals, using the most current research and recommendations. These FAQs address important gaps in HCV knowledge among young adults who are at high risk for infection. The FAQs also highlight the importance of risk reduction counseling provided by frontline public health providers as well as access to safe and effective HCV treatments for young adults who inject drugs.

Public Health

Hepatitis C - drug therapy

Antiviral Agents - therapeutic use

Humans

Substance Abuse, Intravenous - epidemiology

Hispanic Americans

Male

Young Adult

Health Promotion - organization & administration

Hepatitis C - diagnosis

Mass Screening

Health Services Accessibility

New Mexico

Rural Population

Hepatitis C - epidemiology

Counseling

Adult

Female

Details

Title: Subtitle: Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs
Creators: Lauren L Knight - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Katherine Wagner - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Yuridia Leyva - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Veronica R Bruce - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Kirsten A M White - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Yvonne S Talamantes - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Brittany Price - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Kimberly Page - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Martha L Carvour - 1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Resource Type: Journal article
Publication Details: Health promotion practice, Vol.19(6), pp.815-822
DOI: 10.1177/1524839918799455
PMID: 30227752
PMCID: PMC6436913
NLM abbreviation: Health Promot Pract
ISSN: 1524-8399
eISSN: 1552-6372
Grant note: UL1 TR001449 / NCATS NIH HHS U18 PS004568 / NCHHSTP CDC HHS U18PS004568 / ACL HHS R01 DA016017 / NIDA NIH HHS
Language: English
Date published: 11/2018
Academic Unit: Infectious Diseases; Epidemiology; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
Record Identifier: 9984094761202771

Metrics

29 Record Views

1 Times Cited - Web of Science